Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | GFPT1 | Q06210 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | IDE | P14735 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5745153 | 0.96 | FKBP1A (0.48) | FKBP1AALDH1A1MAPTPOLBTP53 | |
| Trifluoroacetic Acid SCHEMBL5809778 | 0.93 | GFPT1 (0.46) | ALDH1A1MAPTGFPT1POLBSMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL5763821 | 0.91 | GAA (0.51) | ALDH1A1MAPTGFPT1POLBSMN1; SMN2 | |
| SCHEMBL6107674 | 0.89 | MAPT (0.45) | FKBP1AALDH1A1MAPTGFPT1POLB | |
| SCHEMBL5765120 | 0.88 | MEN1 (0.45) | ALDH1A1MAPTGFPT1POLBTP53 | |
| Trifluoroacetic Acid SCHEMBL5767572 | 0.88 | ALDH1A1 (0.50) | ALDH1A1MAPTGFPT1SMN1; SMN2KMT2A | |
| SCHEMBL5744564 | 0.87 | GAA (0.55) | ALDH1A1MAPTGFPT1POLBTP53 | |
| SCHEMBL5766705 | 0.86 | MAPK1 (0.51) | ALDH1A1MAPTSMN1; SMN2KMT2AKDM4E | |
| SCHEMBL5744131 | 0.86 | MAPK1 (0.43) | ALDH1A1MAPTGFPT1TP53SMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL5767994 | 0.86 | GFPT1 (0.51) | GFPT1KDM4EMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7067529-B2 | Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors | HOFFMANN-LA ROCHE INC. (US) | 2006-06-27 | — | — | US | disclosed |
| US-20040259910-A1 | Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors | BOLIN DAVID ROBERT (US) | 2004-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040259910-A1 | Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors | GFPT1, GLS2, GLS | FKBP1A 2830/4885ALDH1A1 1211/4885MAPT 1626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.